200 related articles for article (PubMed ID: 34654835)
1. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.
Araujo-Castro M; García Cano A; Jiménez Mendiguchía L; Escobar-Morreale HF; Valderrábano P
Sci Rep; 2021 Oct; 11(1):20539. PubMed ID: 34654835
[TBL] [Abstract][Full Text] [Related]
2. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
[TBL] [Abstract][Full Text] [Related]
4. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study.
Liu MS; Lou Y; Chen H; Wang YJ; Zhang ZW; Li P; Zhu DL
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1789-e1796. PubMed ID: 35137142
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
6. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
[TBL] [Abstract][Full Text] [Related]
7. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
[TBL] [Abstract][Full Text] [Related]
8. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
[TBL] [Abstract][Full Text] [Related]
9. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
[TBL] [Abstract][Full Text] [Related]
10. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
[TBL] [Abstract][Full Text] [Related]
11. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
Carroll TB; Javorsky BR; Findling JW
Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism.
Berndt V; Dahlqvist P; de Verdier J; Ryberg H; Ragnarsson O
Front Endocrinol (Lausanne); 2022; 13():1028804. PubMed ID: 36506050
[TBL] [Abstract][Full Text] [Related]
14. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
[TBL] [Abstract][Full Text] [Related]
15. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
[TBL] [Abstract][Full Text] [Related]
16. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma.
Masserini B; Morelli V; Bergamaschi S; Ermetici F; Eller-Vainicher C; Barbieri AM; Maffini MA; Scillitani A; Ambrosi B; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2009 Jan; 160(1):87-92. PubMed ID: 18835977
[TBL] [Abstract][Full Text] [Related]
17. Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes.
Steffensen C; Thomsen HH; Dekkers OM; Christiansen JS; Rungby J; Jørgensen JO
Clin Endocrinol (Oxf); 2016 Aug; 85(2):202-6. PubMed ID: 27028214
[TBL] [Abstract][Full Text] [Related]
18. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
Patrova J; Kjellman M; Wahrenberg H; Falhammar H
Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
